Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB and G-CSF for Brain Injury and Neurodegenerative Disorders
NCT02236065Completed
- Start
- Aug 2014
- Primary completion
- Jul 2016
- Modality
- Cytokines & Interferons, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Open-label, single-arm trial of umbilical cord blood and filgrastim in traumatic brain injury (TBI), cerebral palsy (CP), amyotrophic lateral sclerosis (ALS) and 1 more. Primary endpoints: Berg Balance Scale at 6 months, Level of Disability at 6 months and 4 more. Started Aug 2014; status: completed.
02
Drugs
umbilical cord bloodfilgrastim
03
Conditions
traumatic brain injury (TBI)cerebral palsy (CP)amyotrophic lateral sclerosis (ALS)Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02236065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236065.